← back to search

Yanfang Zhang

Fujian Medical University · CN
Area of research
Hepatology · Epidemiology
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Epilepsy research and treatment, Pharmacological Effects and Toxicity Studies, and Influenza Virus Research Studies.
h-index
23
citations
2,143
works
163
NIH funding
primary concept
email

Recent publications

Lenvatinib with or without Concurrent Drug-Eluting Beads Transarterial Chemoembolization in Patients with Unresectable, Advanced Hepatocellular Carcinoma: A Real-World, Multicenter, Retrospective Study
Liver Cancer 2022cited by 42position: middledoi
Comparison of minimally-invasive fibular supporting of T-type with traditional bloody iliac flap metastasis for osteonecrosis of the femoral head at ARCO stage II
Heliyon 2022cited by 9position: firstdoi
Benefits of step-by-step debulking microwave ablation for huge unresectable hepatocellular carcinoma patients after transcatheter arterial chemoembolization refractoriness
International Journal of Hyperthermia 2022cited by 3position: middledoi
Application of constrained implants hip arthroplasty in patients with hip neuromuscular disease 
Research Square 2022cited by 0position: firstdoi
Comparison of Minimally-Invasive Fibular Supporting of T-Type with Traditional Bloody Iliac Flap Metastasis for Osteonecrosis of the Femoral Head at ARCO Stage II
SSRN Electronic Journal 2022cited by 0position: firstdoi
Application of constrained implants hip arthroplasty in patients with hip neuromuscular disease
Research Square 2022cited by 0position: firstdoi
Dynamic Changes in the Expression of Interferon-Stimulated Genes in Joints of SPF Chickens Infected With Avian Reovirus
Frontiers in Veterinary Science 2021cited by 17position: middledoi
CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth
Journal of Experimental & Clinical Cancer Research 2019cited by 257position: middledoi
Night shift work and abnormal liver function: is non-alcohol fatty liver a necessary mediator?
Occupational and Environmental Medicine 2018cited by 48position: middledoi
Comparison of simeprevir versus telaprevir plus pegylated interferon alfa and ribavirin in patients with hepatitis C virus genotype 1 infection——a meta-analysis
Zhonghua chuanranbing zazhi 2018cited by 0position: firstdoi
Neuroprotective effects of geniposide in the MPTP mouse model of Parkinson's disease
European Journal of Pharmacology 2015cited by 111position: middledoi
Neuroprotective effects of (Val8)GLP-1-Glu-PAL in the MPTP Parkinson’s disease mouse model
Behavioural Brain Research 2015cited by 50position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Sikai Liu · Henan Polytechnic University4 papers (2022–2022)Yongtai Han · Hebei Medical University4 papers (2022–2022)Mengnan Li · Shanghai Chest Hospital3 papers (2022–2022)Tao Wu · Beijing University of Chinese Medicine3 papers (2022–2022)Bo Liu · Beijing YouAn Hospital2 papers (2022–2022)YiMei Chen · Shanxi Medical University2 papers (2015–2015)Zeming Liu · Beijing University of Chemical Technology2 papers (2022–2022)Xiaobo Wu · Fujian Medical University2 papers (2022–2022)Christian Hölscher · Shanxi Medical University2 papers (2015–2015)Bo Liu · Fuyang City People's Hospital2 papers (2022–2022)Mingqing Xu · Central South University1 papers (2019–2019)Ying Wu · Peking University1 papers (2022–2022)Lin Xie · Shandong University1 papers (2022–2022)Tian Tang · Nanjing University of Chinese Medicine1 papers (2022–2022)Yongguo Li · Harbin Medical University1 papers (2018–2018)Liangliang Xu · Neijiang Normal University1 papers (2019–2019)Tao Wu · Shanghai East Hospital1 papers (2022–2022)Mengnan Li · Hebei Medical University1 papers (2022–2022)Lian Li · Army Medical University1 papers (2019–2019)Shengsheng Ren · Tongji University1 papers (2019–2019)